Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
432 rows where has_cryoEM = 0, in_cev_map = 0 and surface_class = "A_surface" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: aptamer_count_pubmed
surface_class 1
- A_surface · 432 ✖
in_cev_map 1
- - · 432 ✖
has_cryoEM 1
- - · 432 ✖
has_activation_state_pdb_pair 1
- 0 432
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| O95255 | ABCC6 | ATP-binding cassette sub-family C member 6 | Tier 1.5 | 0.809 | 1 | A_surface | 4 | 80.94 | 0 | 0 | 0 | 0 | 0 | Pseudoxanthoma elasticum | 0.864631668818611 | |||
| P07333 | CSF1R | Macrophage colony-stimulating factor 1 receptor | Tier 1 | 0.802 | 1 | A_surface | 26 | 77.81 | 0 | 0 | 1 | 1 | 29277631 | 0 | leukoencephalopathy, diffuse hereditary, with spheroids 1 | 0.8391971566583056 | ||
| P42262 | GRIA2 | Glutamate receptor 2 | Tier 1 | 0.8 | 1 | A_surface | 16 | 84.94 | 0 | 0 | 1 | 4 | 28325839, 19417060, 17929944, 17024188 | 0 | neurodevelopmental disorder with language impairment and behavioral abnormalities | 0.8328652004757138 | ||
| P30968 | GNRHR | Gonadotropin-releasing hormone receptor | Tier 1.5 | 0.799 | 1 | A_surface | 1 | 84.19 | 0 | 0 | 0 | 0 | 0 | hypogonadotropic hypogonadism | 0.83100005285263 | |||
| P10912 | GHR | Growth hormone receptor | Tier 1.5 | 0.799 | 1 | A_surface | 9 | 58.69 | 0 | 0 | 1 | 5 | 38811951, 38477735, 31603904 | 0 | Laron syndrome | 0.8304020079647765 | ||
| Q01974 | ROR2 | Tyrosine-protein kinase transmembrane receptor ROR2 | Tier 1 | 0.794 | 1 | A_surface | 6 | 68.31 | 0 | 0 | 1 | 2 | 41782379, 18673242 | 0 | autosomal recessive Robinow syndrome | 0.8145559265435566 | ||
| Q9UM73 | ALK | ALK tyrosine kinase receptor | Tier 1 | 0.791 | 1 | A_surface | 79 | 68.19 | 0 | 0 | 1 | 6 | 40347134, 38604287, 32218299, 29205808, 24116381, 21281497 | 0 | neuroblastoma | 0.8016889264946979 | ||
| Q12866 | MERTK | Tyrosine-protein kinase Mer | Tier 1 | 0.79 | 1 | A_surface | 42 | 72.25 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.7985580877708576 | |||
| Q4KMG0 | CDON | Cell adhesion molecule-related/down-regulated by oncogenes | Tier 1 | 0.79 | 1 | A_surface | 3 | 62.03 | 0 | 0 | 1 | 3 | 36333824, 24629635, 18698484 | 0 | holoprosencephaly | 0.800378039564866 | ||
| P16871 | IL7R | Interleukin-7 receptor subunit alpha | Tier 1 | 0.789 | 1 | A_surface | 8 | 67.44 | 0 | 0 | 0 | 0 | 0 | immunodeficiency 104 | 0.7983119488718231 | |||
| O43525 | KCNQ3 | Potassium voltage-gated channel subfamily KQT member 3 | Tier 1.5 | 0.789 | 1 | A_surface | 1 | 56.72 | 0 | 0 | 0 | 0 | 0 | Benign familial neonatal seizures | 0.7961763561533409 | |||
| P37023 | ACVRL1 | Activin receptor type-1-like | Tier 1.5 | 0.789 | 1 | A_surface | 7 | 82.0 | 0 | 0 | 0 | 0 | 0 | telangiectasia, hereditary hemorrhagic, type 2 | 0.7951167515831324 | |||
| P15509 | CSF2RA | Granulocyte-macrophage colony-stimulating factor receptor subunit alpha | Tier 1 | 0.788 | 1 | A_surface | 2 | 82.0 | 0 | 0 | 0 | 0 | 0 | Congenital pulmonary alveolar proteinosis | 0.7922592394513138 | |||
| P16410 | CTLA4 | Cytotoxic T-lymphocyte protein 4 | Tier 1.5 | 0.787 | 1 | A_surface | 22 | 80.12 | 0 | 0 | 1 | 26 | 41907643, 40972397, 40870970, 40811947, 40536609, 39417693, 38473398, 38158454, 36966395, 36831533, 36603108, 36015348, 33970170, 32929022, 32840510, 32280743, 32024070, 31405808, 28918052, 28082399, 26030229, 25565435, 24892807, 23460536, 23460531, 14612549 | 0 | autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency | 0.7906408646569979 | ||
| P22223 | CDH3 | Cadherin-3 | Tier 1 | 0.786 | 1 | A_surface | 19 | 76.75 | 0 | 0 | 1 | 1 | 41304780 | 0 | EEM syndrome | 0.7851776755128059 | ||
| Q13698 | CACNA1S | Voltage-dependent L-type calcium channel subunit alpha-1S | Tier 1.5 | 0.786 | 1 | A_surface | 2 | 71.81 | 0 | 0 | 0 | 0 | 0 | hypokalemic periodic paralysis, type 1 | 0.7869997029542154 | |||
| Q96MS0 | ROBO3 | Roundabout homolog 3 | Tier 1.5 | 0.784 | 1 | A_surface | 3 | 63.69 | 0 | 0 | 1 | 2 | 32369590 | 0 | horizontal gaze palsy with progressive scoliosis | 0.7813306356858872 | ||
| Q9H251 | CDH23 | Cadherin-23 | Tier 1 | 0.781 | 1 | A_surface | 6 | 76.75 | 0 | 0 | 0 | 0 | 0 | Usher syndrome type 1 | 0.7713456285400272 | |||
| Q8TDI8 | TMC1 | Transmembrane channel-like protein 1 | Tier 1.5 | 0.781 | 1 | A_surface | 1 | 76.88 | 0 | 0 | 0 | 0 | 0 | autosomal recessive nonsyndromic hearing loss 7 | 0.7694318181814068 | |||
| P21579 | SYT1 | Synaptotagmin-1 | Tier 1 | 0.779 | 1 | A_surface | 24 | 81.81 | 0 | 0 | 0 | 0 | 0 | infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome | 0.7640586502824556 | |||
| Q9NUN7 | ACER3 | Alkaline ceramidase 3 | Tier 1.5 | 0.777 | 1 | A_surface | 2 | 93.19 | 0 | 0 | 0 | 0 | 0 | alkaline ceramidase 3 deficiency | 0.7575827142824458 | |||
| P26678 | PLN | Phospholamban | Tier 1 | 0.775 | 1 | A_surface | 7 | 81.88 | 0 | 0 | 1 | 9 | 39536855, 32382487, 30777430, 25240642, 21848510, 19158349 | 0 | hypertrophic cardiomyopathy | 0.750557685745381 | ||
| Q9HBE5 | IL21R | Interleukin-21 receptor | Tier 1 | 0.775 | 1 | A_surface | 6 | 64.12 | 0 | 0 | 1 | 2 | 30800133, 29244152 | 0 | Cryptosporidiosis - chronic cholangitis - liver disease | 0.7501392499286187 | ||
| Q9Y6Q6 | TNFRSF11A | Tumor necrosis factor receptor superfamily member 11A | Tier 1 | 0.775 | 1 | A_surface | 1 | 58.91 | 0 | 0 | 1 | 1 | 15562003 | 0 | Osteopetrosis - hypogammaglobulinemia | 0.7487328542164448 | ||
| P40126 | DCT | L-dopachrome tautomerase | Tier 1.5 | 0.774 | 1 | A_surface | 1 | 89.12 | 0 | 0 | 1 | 1 | 27245069 | 0 | oculocutaneous albinism type 8 | 0.7468868816172217 | ||
| Q9Y6J6 | KCNE2 | Potassium voltage-gated channel subfamily E member 2 | Tier 1.5 | 0.772 | 1 | A_surface | 1 | 78.25 | 0 | 0 | 0 | 0 | 0 | Romano-Ward syndrome | 0.739531738338193 | |||
| Q9NR97 | TLR8 | Toll-like receptor 8 | Tier 1 | 0.771 | 1 | A_surface | 39 | 86.12 | 0 | 0 | 1 | 4 | 40085160, 39956743 | 0 | immunodeficiency 98 with autoinflammation, X-linked | 0.7360623201088097 | ||
| O43914 | TYROBP | TYRO protein tyrosine kinase-binding protein | Tier 1.5 | 0.77 | 1 | A_surface | 5 | 64.62 | 0 | 0 | 0 | 0 | 0 | Nasu-Hakola disease | 0.7323368313860329 | |||
| Q96E22 | NUS1 | Dehydrodolichyl diphosphate synthase complex subunit NUS1 | Tier 1 | 0.769 | 1 | A_surface | 9 | 82.0 | 0 | 0 | 0 | 0 | 0 | congenital disorder of glycosylation type I | 0.7309837554022756 | |||
| P26842 | CD27 | CD27 antigen | Tier 1 | 0.763 | 1 | A_surface | 5 | 71.69 | 0 | 0 | 1 | 3 | 39841045, 30609550, 26320067 | 0 | lymphoproliferative syndrome 2 | 0.7084378623696481 | ||
| P15941 | MUC1 | Mucin-1 | Tier 1 | 0.761 | 1 | A_surface | 23 | 47.41 | 0 | 0 | 1 | 686 | 42025056, 41988862, 41954302, 41771296, 41744704, 41744190, 41657320, 41627316, 41621292, 41582516, 41535857, 41471303, 41362016, 41352919, 41346179, 41330302, 41243570, 41205458, 41185018, 41101154, 41047832, 41027169, 40682599, 40665615, 40627939, 40607530, 40590839, 40578633, 40568899, 40556592, 40504676, 40500890, 40499867, 40479828, 40432219, 40422041, 40360093, 40286646, 40274149, 40158809, 40119836, 39978149, 39910821, 39705316, 39679901, 39626346, 39579679, 39566700, 39552005, 39550818, 41997681, 41247195, 40813258, 39454542, 39454415, 39440615, 39421884, 39406784, 39256285, 39243449, 39154820, 39142532, 39136402, 39119745, 39118454, 38923850, 38912896 | 0 | tubulointerstitial kidney disease, autosomal dominant, 2 | 0.7040398435219726 | ||
| P48023 | FASLG | Tumor necrosis factor ligand superfamily member 6 | Tier 1.5 | 0.76 | 1 | A_surface | 3 | 80.19 | 0 | 0 | 1 | 1 | 16581027 | 0 | autoimmune lymphoproliferative syndrome type 1 | 0.6984292519156657 | ||
| O14788 | TNFSF11 | Tumor necrosis factor ligand superfamily member 11 | Tier 1 | 0.759 | 1 | A_surface | 2 | 79.19 | 0 | 0 | 1 | 2 | 15562003, 41226313 | 0 | osteoporosis | 0.6957850224892792 | ||
| O00305 | CACNB4 | Voltage-dependent L-type calcium channel subunit beta-4 | Tier 1.5 | 0.757 | 1 | A_surface | 1 | 71.81 | 0 | 0 | 0 | 0 | 0 | episodic ataxia type 5 | 0.6883498385715039 | |||
| Q13002 | GRIK2 | Glutamate receptor ionotropic, kainate 2 | Tier 1.5 | 0.757 | 1 | A_surface | 2 | 83.56 | 0 | 0 | 0 | 0 | 0 | intellectual disability, autosomal recessive 6 | 0.6913183275248935 | |||
| Q9UL01 | DSE | Dermatan-sulfate epimerase | Tier 1.5 | 0.755 | 1 | A_surface | 1 | 86.56 | 0 | 0 | 0 | 0 | 0 | Ehlers-Danlos syndrome, musculocontractural type | 0.6849286764746361 | |||
| O43570 | CA12 | Carbonic anhydrase 12 | Tier 1 | 0.754 | 1 | A_surface | 40 | 87.81 | 0 | 0 | 0 | 0 | 0 | isolated hyperchlorhidrosis | 0.6794515382695604 | |||
| Q02223 | TNFRSF17 | Tumor necrosis factor receptor superfamily member 17 | Tier 1 | 0.753 | 1 | A_surface | 11 | 64.94 | 0 | 0 | 0 | 0 | 0 | multiple myeloma | 0.6779550435975632 | |||
| P32970 | CD70 | CD70 antigen | Tier 1.5 | 0.75 | 1 | A_surface | 1 | 83.19 | 0 | 0 | 1 | 1 | 30609550 | 0 | severe combined immunodeficiency due to CD70 deficiency | 0.6651491980619259 | ||
| Q9NYG8 | KCNK4 | Potassium channel subfamily K member 4 | Tier 1 | 0.749 | 1 | A_surface | 12 | 78.69 | 0 | 0 | 0 | 0 | 0 | facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome | 0.6619991022563834 | |||
| Q9HCK4 | ROBO2 | Roundabout homolog 2 | Tier 1.5 | 0.744 | 1 | A_surface | 6 | 67.38 | 0 | 0 | 1 | 2 | 40616090, 31640794 | 0 | familial vesicoureteral reflux | 0.6460375744556555 | ||
| Q13454 | TUSC3 | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 | Tier 1 | 0.743 | 1 | A_surface | 4 | 84.75 | 0 | 0 | 0 | 0 | 0 | autosomal recessive non-syndromic intellectual disability | 0.6445043495923901 | |||
| P48551 | IFNAR2 | Interferon alpha/beta receptor 2 | Tier 1 | 0.743 | 1 | A_surface | 9 | 64.44 | 0 | 0 | 1 | 1 | 35212764 | 0 | COVID-19 | 0.6417504201511338 | ||
| Q15116 | PDCD1 | Programmed cell death protein 1 | Tier 1 | 0.738 | 1 | A_surface | 37 | 74.12 | 0 | 0 | 1 | 27 | 41479885, 40811947, 40758411, 39562585, 37424077, 34156677, 33904236, 33896107, 33319876, 33155587, 32574155, 32429721, 31727249, 31434881, 28912094, 28288993, 41907643, 41125194, 38158454, 37944524, 36484532, 36015348, 34861397, 34386332 | 0 | melanoma | 0.6260691959208758 | ||
| Q9NR96 | TLR9 | Toll-like receptor 9 | Tier 1 | 0.736 | 1 | A_surface | 3 | 86.75 | 0 | 0 | 1 | 30 | 41617261, 40657739, 39841045, 39830661, 33896107, 32143069, 28594360, 26003847, 23046187, 22174879, 19325804, 18495099, 12828856, 37161583, 34730968, 30526333, 29450964, 17665991 | 0 | rheumatoid arthritis | 0.6213924969410908 | ||
| P19235 | EPOR | Erythropoietin receptor | Tier 1 | 0.735 | 1 | A_surface | 21 | 66.94 | 0 | 0 | 1 | 6 | 31904170, 31279934, 20142506, 41207063 | 0 | anemia (phenotype) | 0.6151472861334055 | ||
| Q8N126 | CADM3 | Cell adhesion molecule 3 | Tier 1.5 | 0.735 | 1 | A_surface | 1 | 84.38 | 0 | 0 | 1 | 2 | 39263947 | 0 | Charcot-Marie-Tooth disease, axonal, type 2FF | 0.6157861516342734 | ||
| P29274 | ADORA2A | Adenosine receptor A2a | Tier 1 | 0.733 | 1 | A_surface | 99 | 80.38 | 0 | 0 | 0 | 0 | 0 | migraine disorder | 0.6090172565654923 | |||
| P40200 | CD96 | T-cell surface protein tactile | Tier 1 | 0.731 | 1 | A_surface | 1 | 64.94 | 0 | 0 | 0 | 0 | 0 | C syndrome | 0.6042901819592128 | |||
| O43613 | HCRTR1 | Orexin/Hypocretin receptor type 1 | Tier 1 | 0.729 | 1 | A_surface | 14 | 78.81 | 0 | 0 | 0 | 0 | 0 | insomnia | 0.5956659546129768 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;